Cancer Antigen 19-9
Test Code
CA199
Associations
Pancreatic cancer
Methodology
Chemilumninescent Immunoassay
CPT Codes
86301 - CA 19-9
Turnaround Time
< 24 hours
Specimen Requirements
7.0 mL serum, gold or red serum separator tube
Specimen Stability
Storage & Handling
Causes for Rejection
Specimen age or temperature exceeded
Reference Range
See report
Description
CA 19-9 is a tumor marker used in the prognosis of pancreatic cancer. It is consider the best serum marker because of its high sensitivity and specificity. Usually, the tumor marker is not seen as useful in screening asymptomatic populations for pancreatic cancer, but its effectiveness has shown useful in studies of advanced cancer.
References
- Berger Adam et al. (2008). Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. Journal of Clinical Oncology. Vol 26, No 36; 5918-5922.
- Kim JE et al. (2004). Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. Feb;19(2):182-6.
